The effect of estrogen deficiency on receptor activator of nuclear factor kappa B ligand and osteoprotegerin synthesis in periapical lesions induced in rats

被引:25
作者
Zhang, Xiaolei
Peng, Bin
Fan, Mingwen
Bian, Zhuan
Chen, Zhi
机构
[1] Wuhan Univ, Minist Educ, Key Lab Oral Biomed Engn, Sch & Hosp Stomatol,Dept Conservat Dent & Endodon, Wuhan 430079, Peoples R China
[2] Tongji Univ, Sch & Hosp Stomatol, Shanghai 200092, Peoples R China
关键词
estrogen; OPG; periapical lesion; RANKL;
D O I
10.1016/j.joen.2007.04.005
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The aim of this research was to study the effects of estrogen deficiency on the receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) synthesis in the periapical lesions that were induced in ovariectomized (OVX) and sham-ovariectomized (Sham) rats. After mandibles were collected, the enzyme histochemical test for tartrate-resistant acid phosphatase and immunohistochemical examination for RANKL and OPG were performed. On days 0, 7, and 28, the numbers of osteoclasts in the periapical areas of the OVX rats were significantly more than those of the Sham group. The data had statistical differences on days 7, 21, and 28 for RANKL-positive cells between the 2 groups. The number of OPG-positive cells of the OVX rats was more than that of the Sham group at the early stage of estrogen deficiency (day 7). Estrogen deficiency-induced severe periapical bone resorption might be mediated by overexpression of RANKL. At the early stage of estrogen deficiency, the osteoblastogenesis was also accelerated, which was shown as a kind of reactive protective response.
引用
收藏
页码:1053 / 1056
页数:4
相关论文
共 27 条
[11]   ORAL FINDINGS IN OSTEOPOROSIS .2. RELATIONSHIP BETWEEN RESIDUAL RIDGE AND ALVEOLAR BONE-RESORPTION AND GENERALIZED SKELETAL OSTEOPENIA [J].
KRIBBS, PJ ;
SMITH, DE ;
CHESNUT, CH .
JOURNAL OF PROSTHETIC DENTISTRY, 1983, 50 (05) :719-724
[12]   The menopause, hormone replacement therapy and breast cancer [J].
Marsden, J .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 83 (1-5) :123-132
[14]   Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats [J].
Miyazaki, T ;
Matsunaga, T ;
Miyazaki, S ;
Hokari, S ;
Komoda, T .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 93 (03) :503-512
[15]   THE KNIFE-EDGE TENDENCY IN MANDIBULAR RESIDUAL RIDGES IN WOMEN [J].
NISHIMURA, I ;
HOSOKAWA, R ;
ATWOOD, DA .
JOURNAL OF PROSTHETIC DENTISTRY, 1992, 67 (06) :820-826
[16]   Impaired estrogen sensitivity in bone by inhibiting both estrogen receptor α and β pathways [J].
Ogawa, S ;
Fujita, M ;
Ishii, Y ;
Tsurukami, H ;
Hirabayashi, M ;
Ikeda, K ;
Orimo, A ;
Hosoi, T ;
Ueda, M ;
Nakamura, T ;
Ouchi, Y ;
Muramatsu, M ;
Inoue, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (28) :21372-21379
[17]   Osteoprotegerin: A novel secreted protein involved in the regulation of bone density [J].
Simonet, WS ;
Lacey, DL ;
Dunstan, CR ;
Kelley, M ;
Chang, MS ;
Luthy, R ;
Nguyen, HQ ;
Wooden, S ;
Bennett, L ;
Boone, T ;
Shimamoto, G ;
DeRose, M ;
Elliott, R ;
Colombero, A ;
Tan, HL ;
Trail, G ;
Sullivan, J ;
Davy, E ;
Bucay, N ;
RenshawGegg, L ;
Hughes, TM ;
Hill, D ;
Pattison, W ;
Campbell, P ;
Sander, S ;
Van, G ;
Tarpley, J ;
Derby, P ;
Lee, R ;
Boyle, WJ .
CELL, 1997, 89 (02) :309-319
[18]   The actions and interactions of sex steroids and growth factors cytokines on the skeleton [J].
Spelsberg, TC ;
Subramaniam, M ;
Riggs, BL ;
Khosla, S .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (06) :819-828
[19]   Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-κB ligand (RANKL)-induced JNK activation [J].
Srivastava, S ;
Toraldo, G ;
Weitzmann, MN ;
Cenci, S ;
Ross, FP ;
Pacifici, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) :8836-8840
[20]   Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families [J].
Suda, T ;
Takahashi, N ;
Udagawa, N ;
Jimi, E ;
Gillespie, MT ;
Martin, TJ .
ENDOCRINE REVIEWS, 1999, 20 (03) :345-357